AKT1 and nonpapillary renal cell carcinoma: PTEN acts as a negative regulator of the AKT and TNF/NF-kappa B signaling pathways 13, and abnormal activation of AKT and TNF/NF-kappa B signaling contributes to TKI resistance in ccRCC 30, 31.